Nalaganje...
Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma
Indolent CNS lymphomas (CNSLs) are rare and no guidelines exist for management. Recent literature highlights the potential for safe and tolerable intrathecal (IT) delivery of rituximab, a large anti-CD20 monoclonal antibody, for aggressive CNSL. We report a patient with relapsed indolent CNSL who fa...
Shranjeno v:
| izdano v: | CNS Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Future Medicine Ltd
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4778415/ https://ncbi.nlm.nih.gov/pubmed/25905905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|